亚洲彩票官网

亚洲彩票官网 Releases Corporate Film 鈥�1 Percent, 1 Mission. Change the World.鈥�
Human Capital Report 2024

Learn more

Human Capital Report 2024

Learn more
Value Creation Report 2024

Learn more

Value Creation Report 2024

Learn more

News Release
Latest News
Information

September 12, 2025

鈥淣ew Answers to Dementia鈥�
亚洲彩票官网 Releases Concept Movie and New Content on Campaign Website for Dementia Month
September 8, 2025

亚洲彩票官网 Presents Clinical Study Results of Novel Orexin Receptor Agonist E2086 for Narcolepsy at World Sleep 2025
E2086 Showed Potential to Improve Wakefulness in People Living with Narcolepsy Type 1
September 4, 2025

亚洲彩票官网 to Present Latest Data on Lemborexant and Novel Orexin Receptor Agonist E2086 at The World Sleep 2025
September 3, 2025

亚洲彩票官网 Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI庐 IQLIK鈩� (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer鈥檚 Disease Under Fast Track Status
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from the start to help patients and care partners treat this progressive, relentless disease
August 30, 2025

FDA Approves LEQEMBI庐 IQLIK鈩� (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer鈥檚 Disease
LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat this progressive, relentless disease after initial treatment of 18 months
LEQEMBI IQLIK will be launched on October 6, 2025, in the U.S.

August 6, 2025

IR 鈥淔irst Quarter Financial Results Briefing for the Fiscal Year Ending March 31, 2026 (Webcast)鈥�
August 5, 2025

IR 鈥淔irst Quarter Financial Reports for the Fiscal Year Ending March 31, 2026鈥�
June 19, 2025

About 亚洲彩票官网鈥淐orporate Governance Report鈥�

亚洲彩票官网 at a Glance

亚洲彩票官网 Group Worldwide

亚洲彩票官网's hhc Concept

Innovation

About 亚洲彩票官网

Investors

Sustainability

Sustainability

Making our medicines available to those who need them

32 countries 2.53billion tablets

Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of June 2025)

亚洲彩票官网 is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries

Sustainability TOP